|
Name |
Succinic acid, 2-ethylhexyl 2-methyl-3-pentyl ester
|
Molecular Formula | C18H34O4 | |
IUPAC Name* |
1-O-(2-ethylhexyl) 4-O-(2-methylpentan-3-yl) butanedioate
|
|
SMILES |
CCCCC(CC)COC(=O)CCC(=O)OC(CC)C(C)C
|
|
InChI |
InChI=1S/C18H34O4/c1-6-9-10-15(7-2)13-21-17(19)11-12-18(20)22-16(8-3)14(4)5/h14-16H,6-13H2,1-5H3
|
|
InChIKey |
LLNCSQDIIPSGPU-UHFFFAOYSA-N
|
|
Synonyms |
Succinic acid, 2-ethylhexyl 2-methyl-3-pentyl ester
|
|
CAS | NA | |
PubChem CID | 91698730 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 314.5 | ALogp: | 5.3 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 14 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 52.6 | Aromatic Rings: | 0 |
Heavy Atoms: | 22 | QED Weighted: | 0.476 |
Caco-2 Permeability: | -4.492 | MDCK Permeability: | 0.00002320 |
Pgp-inhibitor: | 0.994 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.267 |
30% Bioavailability (F30%): | 0.864 |
Blood-Brain-Barrier Penetration (BBB): | 0.268 | Plasma Protein Binding (PPB): | 96.33% |
Volume Distribution (VD): | 0.416 | Fu: | 2.35% |
CYP1A2-inhibitor: | 0.077 | CYP1A2-substrate: | 0.09 |
CYP2C19-inhibitor: | 0.206 | CYP2C19-substrate: | 0.776 |
CYP2C9-inhibitor: | 0.409 | CYP2C9-substrate: | 0.355 |
CYP2D6-inhibitor: | 0.096 | CYP2D6-substrate: | 0.088 |
CYP3A4-inhibitor: | 0.806 | CYP3A4-substrate: | 0.52 |
Clearance (CL): | 10.031 | Half-life (T1/2): | 0.703 |
hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.068 |
Drug-inuced Liver Injury (DILI): | 0.098 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.013 | Maximum Recommended Daily Dose: | 0.101 |
Skin Sensitization: | 0.819 | Carcinogencity: | 0.142 |
Eye Corrosion: | 0.896 | Eye Irritation: | 0.364 |
Respiratory Toxicity: | 0.247 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000543 | 0.543 | D0X4FM | 0.457 | ||||
ENC000213 | 0.523 | D0AY9Q | 0.347 | ||||
ENC000595 | 0.459 | D00MLW | 0.336 | ||||
ENC000211 | 0.444 | D0Q7ZQ | 0.321 | ||||
ENC003057 | 0.440 | D03LGY | 0.287 | ||||
ENC000212 | 0.403 | D0ZI4H | 0.278 | ||||
ENC000157 | 0.400 | D0H2YX | 0.268 | ||||
ENC000290 | 0.398 | D05PLH | 0.262 | ||||
ENC000228 | 0.379 | D0G2KD | 0.235 | ||||
ENC000933 | 0.366 | D02KBD | 0.235 |